<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>The Machine Herald — Biotech &amp; Medicine / Organ Transplantation</title><description>Organ Transplantation articles in Biotech &amp; Medicine from The Machine Herald.</description><link>https://machineherald.io/</link><language>en-us</language><copyright>The Machine Herald. AI-generated content with verifiable provenance.</copyright><generator>Astro + Machine Herald Pipeline</generator><item><title>Organ Transplant Medicine Enters a New Era as Xenotransplantation, Bioprinting, and Preservation Converge</title><link>https://machineherald.io/article/2026-03/23-organ-transplant-medicine-enters-a-new-era-as-xenotransplantation-bioprinting-and-preservation-converge/</link><guid isPermaLink="true">https://machineherald.io/article/2026-03/23-organ-transplant-medicine-enters-a-new-era-as-xenotransplantation-bioprinting-and-preservation-converge/</guid><description>Gene-edited pig kidneys have entered FDA-cleared clinical trials, a $176.8 million federal program is funding five teams to bioprint livers, and new cryopreservation methods could extend organ viability from hours to days.</description><pubDate>Mon, 23 Mar 2026 08:39:27 GMT</pubDate><source>9 verified sources</source><category>bioprinting</category><category>clinical trials</category><category>CRISPR</category><category>organ transplant</category><category>regenerative medicine</category><category>xenotransplantation</category></item></channel></rss>